Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nexstim Plc (NXTMH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011122
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexstim Plc (Nexstim) is a medical technology company, which focuses on navigated brain stimulation (NBS) to improve rehabilitation in stroke patients non-invasively . Its NBS system, which is FDA cleared and CE-marked, applies navigated transcranial magnetic stimulation (nTMS) device for pre-surgical mapping of the motor and speech cortices. It is also used for research, therapy and neurosurgical planning purposes. Nexstim’s navigated brain therapy (NBT) system is based on the NBS technology platform, focusing on the stimulation of targeted areas in the brain to improve and accelerate stroke rehabilitation. The company offers its products in the US, Finland and other European countries through subsidiaries. Nexstim is headquartered in Helsinki, Finland.

Nexstim Plc (NXTMH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nexstim Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nexstim Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nexstim Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nexstim Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nexstim Plc, Medical Equipment, Deal Details 11
Venture Financing 11
Nexstim Secures Additional US$2.8 Million In Venture Financing Round 11
Partnerships 13
Nexstim Enters into Licensing Agreement with Chinese Partner 13
Nexstim Enters into Co-Operation Agreement with Walton Centre 14
Equity Offering 15
Nexstim to Raise USD2 Million in Private Placement of Shares 15
Nexstim to Raise USD5.5 Million in Private Placement of Shares 16
Nexstim to Raise USD2.2 Million in Private Placement of Shares 18
Nexstim Raises USD5.8 Million in Private Placement of Shares 20
Nexstim Raises USD19 Million in IPO 21
Debt Offering 22
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 22
Nexstim Plc – Key Competitors 24
Nexstim Plc – Key Employees 25
Nexstim Plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 17, 2017: Nexstim Half-yearly Report 1 January – 30 June 2016 (Unaudited) 27
Aug 16, 2017: Nexstim Half-Yearly Report 1 January – 30 June 2017 (Unaudited) 29
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 31
Feb 28, 2017: Nexstim: Financial Statement Release 2016 32
Feb 29, 2016: Nexstim financial statement release 2015 34
Corporate Communications 36
Oct 12, 2017: Change in Nexstim Management Team 36
Sep 26, 2017: Change in Nexstim’s Management Team 37
Aug 03, 2017: Changes in Nexstim’s Management Team 38
Jun 05, 2017: Nexstim Members of the Board Committees 39
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 40
Apr 24, 2017: Nexstim Appoints Hanna Kotola as VP of Legal Affairs 41
Mar 28, 2017: Nexstim: The decisions of the Board of Directors 42
Mar 09, 2017: Changes in Nexstim Management Team 43
Apr 21, 2016: Nexstim announces the change of CEO 44
Apr 01, 2016: Nexstim Appoints John Liedtky as VP of Commercialisation, General Manager US and announces the retirement of John Hardin 45
Product News 46
Jan 31, 2017: Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system 46
Oct 05, 2016: Nexstim Key Technology Patent Granted in EU 47
Other Significant Developments 48
Oct 16, 2017: Nexstim is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US 48
May 08, 2017: Nexstim Terminates Market Making Agreement with Pareto Securities in Nasdaq First North Sweden 49
Apr 24, 2017: Aarhus University Hospital in Denmark Purchases NBS System from Nexstim 50
Mar 08, 2017: Nexstim announces signing of an Independent Selling Representative Agreement in the U.S. with Surgical Solutions 51
Jan 11, 2017: Nexstim announces signing of an Independent Selling Representative Agreements in U.S. 52
Dec 22, 2016: Nexstim pre-close business update 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Nexstim Plc, Medical Equipment, Key Facts, 2015 2
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nexstim Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nexstim Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nexstim Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nexstim Plc, Deals By Market, 2011 to YTD 2017 9
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nexstim Secures Additional US$2.8 Million In Venture Financing Round 11
Nexstim Enters into Licensing Agreement with Chinese Partner 13
Nexstim Enters into Co-Operation Agreement with Walton Centre 14
Nexstim to Raise USD2 Million in Private Placement of Shares 15
Nexstim to Raise USD5.5 Million in Private Placement of Shares 16
Nexstim to Raise USD2.2 Million in Private Placement of Shares 18
Nexstim Raises USD5.8 Million in Private Placement of Shares 20
Nexstim Raises USD19 Million in IPO 21
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 22
Nexstim Plc, Key Competitors 24
Nexstim Plc, Key Employees 25
Nexstim Plc, Subsidiaries 26

★海外企業調査レポート[Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Schroders Plc:企業の戦略・SWOT・財務情報
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Salk Institute for Biological Studies:製薬・医療:M&Aディール及び事業提携情報
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise aging and regenerative medicine, cancer biology, immune system biology, metabolism and diabetes, neuroscience and neurological disorders, …
  • The Royal Bank of Scotland Group Plc:企業の戦略・SWOT・財務情報
    The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • XERIS Pharmaceuticals Inc (XERS):製薬・医療:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • China Resources Beer (Holdings) Co Ltd:戦略・SWOT・企業財務分析
    China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Brown Advisory Inc:企業の戦略・SWOT・財務分析
    Brown Advisory Inc - Strategy, SWOT and Corporate Finance Report Summary Brown Advisory Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Black Knight Inc (BKI):企業の財務・戦略的SWOT分析
    Black Knight Inc (BKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Immunodiagnostic Systems Holdings plc (IDH):医療機器:M&Aディール及び事業提携情報
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • 23andMe Inc-製薬・医療分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • Q.E.P. Co Inc (QEPC):企業の財務・戦略的SWOT分析
    Summary Q.E.P. Co Inc (QEP) is a consumer goods providing company that offers specialty tools and flooring related products. The company offers products such as adhesives, grouts and mortars, hardwood flooring, pneumatic nailers, stone and tile installation, sundries, surface protection, suspended c …
  • LyondellBasell Industries NV (LYB):企業の財務・戦略的SWOT分析
    LyondellBasell Industries NV (LYB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • City National Wealth Management:企業の戦略・SWOT・財務分析
    City National Wealth Management - Strategy, SWOT and Corporate Finance Report Summary City National Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Petro-Victory Energy Corp (VRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Petro-Victory Energy Corp (Petro-Victory) is an oil and gas company that provides exploration and production of hydrocarbon, oil and natural gas resources. The company provides onshore exploration to identify prospective resources, promote and initiate drilling campaigns to find hydrocarbon …
  • Pyng Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pyng Medical Corp (Pyng Medical), a subsidiary of Teleflex Medical Canada Inc, is a medical device company that manufactures and markets trauma and resuscitation products. The company offers products such as fast1 intraosseous infusion system, fastresponder sternal intraosseous device, mat t …
  • Qorvo Inc (QRVO):企業の財務・戦略的SWOT分析
    Qorvo Inc (QRVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • De La Rue Plc
    De La Rue Plc - Strategy, SWOT and Corporate Finance Report Summary De La Rue Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆